Diagnostic value of fasting plasma peptide concentrations in patients with chronic diarrhea

Lawrence R. Schiller, Lydia M. Rivera, William C. Santangelo, Katherine H. Little, John S. Fordtran

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

To evaluate the utility of screening for multiple gastrointestinal peptides in the evaluation of patients with chronic diarrhea, we studied 193 patients referred for evaluation of chronic diarrhea and eight patients with known peptide-secreting tumors as a reference group. Fasting plasma samples were assayed for motilin, neurotensin, pancreatic polypeptide, somatostatin, substance P, vasoactive intestinal polypeptide, gastrin-releasing peptide, and calcitonin during a protocol evaluation for causes of chronic diarrhea. Although none of the referred patients were found to have tumors, abnormal levels of one or more peptides were found in 86 of 193 patients (45%). Abnormal plasma peptide levels were sometimes as high in these patients as in patients with known peptide-secreting tumors and would have led to mistaken diagnoses of tumors much more often than they would have led to correct diagnoses. The positive predictive value of elevation of any assayed peptide was<2% at realistic prevalence rates for peptide-secreting tumors; the negative predictive value of a series of normal results was>99%, but much of this was due to the rarity of these tumors. Patients with chronic diarrhea should not be screened routinely with a panel of plasma peptide assays in an effort to detect tumors; instead, peptide levels should be ordered selectively. Elevated fasting concentrations of the plasma peptides measured in this study are most likely epiphenomena due to diarrhea and should not be the sole basis for invasive diagnostic or surgical management of these patients.

Original languageEnglish (US)
Pages (from-to)2216-2222
Number of pages7
JournalDigestive Diseases and Sciences
Volume39
Issue number10
DOIs
StatePublished - Oct 1 1994

Fingerprint

Diarrhea
Fasting
Peptides
Neoplasms
Gastrin-Releasing Peptide
Motilin
Pancreatic Polypeptide
Neurotensin
Vasoactive Intestinal Peptide
Calcitonin
Substance P
Somatostatin

Keywords

  • carcinoid tumors
  • chronic diarrhea
  • endocrine tumors
  • gastrointestinal peptides

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Diagnostic value of fasting plasma peptide concentrations in patients with chronic diarrhea. / Schiller, Lawrence R.; Rivera, Lydia M.; Santangelo, William C.; Little, Katherine H.; Fordtran, John S.

In: Digestive Diseases and Sciences, Vol. 39, No. 10, 01.10.1994, p. 2216-2222.

Research output: Contribution to journalArticle

Schiller, Lawrence R. ; Rivera, Lydia M. ; Santangelo, William C. ; Little, Katherine H. ; Fordtran, John S. / Diagnostic value of fasting plasma peptide concentrations in patients with chronic diarrhea. In: Digestive Diseases and Sciences. 1994 ; Vol. 39, No. 10. pp. 2216-2222.
@article{fa97d17156c74fc3a706f5f3a1dc05d8,
title = "Diagnostic value of fasting plasma peptide concentrations in patients with chronic diarrhea",
abstract = "To evaluate the utility of screening for multiple gastrointestinal peptides in the evaluation of patients with chronic diarrhea, we studied 193 patients referred for evaluation of chronic diarrhea and eight patients with known peptide-secreting tumors as a reference group. Fasting plasma samples were assayed for motilin, neurotensin, pancreatic polypeptide, somatostatin, substance P, vasoactive intestinal polypeptide, gastrin-releasing peptide, and calcitonin during a protocol evaluation for causes of chronic diarrhea. Although none of the referred patients were found to have tumors, abnormal levels of one or more peptides were found in 86 of 193 patients (45{\%}). Abnormal plasma peptide levels were sometimes as high in these patients as in patients with known peptide-secreting tumors and would have led to mistaken diagnoses of tumors much more often than they would have led to correct diagnoses. The positive predictive value of elevation of any assayed peptide was<2{\%} at realistic prevalence rates for peptide-secreting tumors; the negative predictive value of a series of normal results was>99{\%}, but much of this was due to the rarity of these tumors. Patients with chronic diarrhea should not be screened routinely with a panel of plasma peptide assays in an effort to detect tumors; instead, peptide levels should be ordered selectively. Elevated fasting concentrations of the plasma peptides measured in this study are most likely epiphenomena due to diarrhea and should not be the sole basis for invasive diagnostic or surgical management of these patients.",
keywords = "carcinoid tumors, chronic diarrhea, endocrine tumors, gastrointestinal peptides",
author = "Schiller, {Lawrence R.} and Rivera, {Lydia M.} and Santangelo, {William C.} and Little, {Katherine H.} and Fordtran, {John S.}",
year = "1994",
month = "10",
day = "1",
doi = "10.1007/BF02090374",
language = "English (US)",
volume = "39",
pages = "2216--2222",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "10",

}

TY - JOUR

T1 - Diagnostic value of fasting plasma peptide concentrations in patients with chronic diarrhea

AU - Schiller, Lawrence R.

AU - Rivera, Lydia M.

AU - Santangelo, William C.

AU - Little, Katherine H.

AU - Fordtran, John S.

PY - 1994/10/1

Y1 - 1994/10/1

N2 - To evaluate the utility of screening for multiple gastrointestinal peptides in the evaluation of patients with chronic diarrhea, we studied 193 patients referred for evaluation of chronic diarrhea and eight patients with known peptide-secreting tumors as a reference group. Fasting plasma samples were assayed for motilin, neurotensin, pancreatic polypeptide, somatostatin, substance P, vasoactive intestinal polypeptide, gastrin-releasing peptide, and calcitonin during a protocol evaluation for causes of chronic diarrhea. Although none of the referred patients were found to have tumors, abnormal levels of one or more peptides were found in 86 of 193 patients (45%). Abnormal plasma peptide levels were sometimes as high in these patients as in patients with known peptide-secreting tumors and would have led to mistaken diagnoses of tumors much more often than they would have led to correct diagnoses. The positive predictive value of elevation of any assayed peptide was<2% at realistic prevalence rates for peptide-secreting tumors; the negative predictive value of a series of normal results was>99%, but much of this was due to the rarity of these tumors. Patients with chronic diarrhea should not be screened routinely with a panel of plasma peptide assays in an effort to detect tumors; instead, peptide levels should be ordered selectively. Elevated fasting concentrations of the plasma peptides measured in this study are most likely epiphenomena due to diarrhea and should not be the sole basis for invasive diagnostic or surgical management of these patients.

AB - To evaluate the utility of screening for multiple gastrointestinal peptides in the evaluation of patients with chronic diarrhea, we studied 193 patients referred for evaluation of chronic diarrhea and eight patients with known peptide-secreting tumors as a reference group. Fasting plasma samples were assayed for motilin, neurotensin, pancreatic polypeptide, somatostatin, substance P, vasoactive intestinal polypeptide, gastrin-releasing peptide, and calcitonin during a protocol evaluation for causes of chronic diarrhea. Although none of the referred patients were found to have tumors, abnormal levels of one or more peptides were found in 86 of 193 patients (45%). Abnormal plasma peptide levels were sometimes as high in these patients as in patients with known peptide-secreting tumors and would have led to mistaken diagnoses of tumors much more often than they would have led to correct diagnoses. The positive predictive value of elevation of any assayed peptide was<2% at realistic prevalence rates for peptide-secreting tumors; the negative predictive value of a series of normal results was>99%, but much of this was due to the rarity of these tumors. Patients with chronic diarrhea should not be screened routinely with a panel of plasma peptide assays in an effort to detect tumors; instead, peptide levels should be ordered selectively. Elevated fasting concentrations of the plasma peptides measured in this study are most likely epiphenomena due to diarrhea and should not be the sole basis for invasive diagnostic or surgical management of these patients.

KW - carcinoid tumors

KW - chronic diarrhea

KW - endocrine tumors

KW - gastrointestinal peptides

UR - http://www.scopus.com/inward/record.url?scp=0027997688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027997688&partnerID=8YFLogxK

U2 - 10.1007/BF02090374

DO - 10.1007/BF02090374

M3 - Article

C2 - 7924745

AN - SCOPUS:0027997688

VL - 39

SP - 2216

EP - 2222

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 10

ER -